WO2012019430A8 - 酞嗪酮类衍生物、其制备方法及其在医药上的应用 - Google Patents
酞嗪酮类衍生物、其制备方法及其在医药上的应用 Download PDFInfo
- Publication number
- WO2012019430A8 WO2012019430A8 PCT/CN2011/001268 CN2011001268W WO2012019430A8 WO 2012019430 A8 WO2012019430 A8 WO 2012019430A8 CN 2011001268 W CN2011001268 W CN 2011001268W WO 2012019430 A8 WO2012019430 A8 WO 2012019430A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- pharmaceutical use
- phthalazinone derivative
- derivative
- phthalazinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201180004612.2A CN102762549B (zh) | 2010-08-10 | 2011-08-02 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
TW100141560A TW201307349A (zh) | 2011-08-02 | 2011-11-15 | 酞嗪酮類衍生物、其製備方法及其在醫藥上的應用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102496361A CN102372698A (zh) | 2010-08-10 | 2010-08-10 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
CN201010249636.1 | 2010-08-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012019430A1 WO2012019430A1 (zh) | 2012-02-16 |
WO2012019430A8 true WO2012019430A8 (zh) | 2012-05-10 |
Family
ID=45567317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2011/001268 WO2012019430A1 (zh) | 2010-08-10 | 2011-08-02 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN102372698A (zh) |
WO (1) | WO2012019430A1 (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102766135B (zh) * | 2012-07-09 | 2017-05-03 | 云南大学 | 二氢呋喃并茚烷‑咪唑盐类化合物及其制备方法 |
CN103724352B (zh) * | 2012-10-16 | 2017-11-28 | 江苏盛迪医药有限公司 | 一种dpp‑iv抑制剂的中间体、其制备方法和通过其制备dpp‑iv抑制剂的方法 |
MA38080A1 (fr) * | 2012-12-31 | 2018-02-28 | Cadila Healthcare Ltd | Dérivés substitués de phtalazin-1(2h)-one comme inhibiteurs sélectifs de la poly(adp-ribose) polymérase-1 |
CA2905751A1 (en) | 2013-03-13 | 2014-10-09 | Forma Therapeutics, Inc. | Novel compounds and compositions for inhibition of fasn |
KR101670126B1 (ko) | 2013-09-13 | 2016-10-27 | 일동제약(주) | 신규 프탈라지논 유도체 및 그 제조방법 |
US10487123B2 (en) | 2014-10-16 | 2019-11-26 | Monsanto Technology Llc | Chimeric insecticidal proteins toxic or inhibitory to lepidopteran pests |
MA45918A (fr) | 2016-08-15 | 2019-06-19 | Bayer Ag | Dérivés hétérocycliques bicycliques condensés utilisés comme pesticides |
CN110087730B (zh) * | 2016-09-27 | 2023-03-28 | 百济神州(苏州)生物科技有限公司 | 使用包含parp抑制剂的组合产品治疗癌症 |
CN108727391A (zh) * | 2017-04-21 | 2018-11-02 | 上海迪诺医药科技有限公司 | Parp抑制剂化合物非晶形及其制备方法和应用 |
WO2018192576A1 (zh) * | 2017-04-21 | 2018-10-25 | 上海迪诺医药科技有限公司 | Parp抑制化合物的制备方法、其中间体、非晶形、溶剂合物、药物组合物及应用 |
WO2019002344A1 (en) | 2017-06-29 | 2019-01-03 | Lonza Guangzhou Nansha Ltd. | PROCESS FOR THE PREPARATION OF ALPHA-METHYL-L-PROLINE |
CN108341792B (zh) * | 2018-04-28 | 2021-09-17 | 苏州莱克施德药业有限公司 | 一种Volasertib中间体1-环丙基甲基哌嗪的制备方法 |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
WO2020092395A1 (en) | 2018-10-29 | 2020-05-07 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
MX2021005764A (es) | 2018-11-16 | 2021-10-01 | Jiangsu Hengrui Medicine Co | Composición farmacéutica que comprende inhibidores de poli (adenosina difosfato (adp)-ribosa) polimerasas (parp). |
CN111138335B (zh) * | 2020-01-14 | 2021-10-01 | 山东四环药业股份有限公司 | 一种光学活性2-甲基脯氨酸的制备方法 |
CN115702151A (zh) | 2020-04-21 | 2023-02-14 | 伊迪恩斯股份有限公司 | 酞嗪酮化合物的结晶形式 |
CN111606842A (zh) * | 2020-05-27 | 2020-09-01 | 安徽中羰碳一工业技术有限责任公司 | 一种2-(4-哌啶基)-2-丙醇及其盐酸盐的制备方法 |
CN114685374B (zh) * | 2020-12-28 | 2024-04-12 | 山东道合药业有限公司 | 一种合成奥拉帕尼的新工艺 |
CN112679411B (zh) * | 2020-12-31 | 2022-04-01 | 上海再启生物技术有限公司 | 一种手性5-(甲胺基)六氢环戊并[c]吡咯-2(1H)-Boc甲磺酸盐的制备方法 |
CN112624981B (zh) * | 2021-03-09 | 2021-05-25 | 南京桦冠生物技术有限公司 | 一种2-氟-5-[(4-氧代-3h-2,3-二氮杂萘基)甲基]苯甲酸的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0419072D0 (en) * | 2004-08-26 | 2004-09-29 | Kudos Pharm Ltd | Phthalazinone derivatives |
EP1953147A1 (en) * | 2005-11-21 | 2008-08-06 | Japan Tobacco, Inc. | Heterocyclic compound and medicinal application thereof |
TW200900396A (en) * | 2007-04-10 | 2009-01-01 | Kudos Pharm Ltd | Phthalazinone derivatives |
US20090023727A1 (en) * | 2007-07-05 | 2009-01-22 | Muhammad Hashim Javaid | Phthalazinone derivatives |
-
2010
- 2010-08-10 CN CN2010102496361A patent/CN102372698A/zh active Pending
-
2011
- 2011-08-02 CN CN201180004612.2A patent/CN102762549B/zh not_active Expired - Fee Related
- 2011-08-02 WO PCT/CN2011/001268 patent/WO2012019430A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN102762549B (zh) | 2015-05-27 |
CN102372698A (zh) | 2012-03-14 |
CN102762549A (zh) | 2012-10-31 |
WO2012019430A1 (zh) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012019426A8 (zh) | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 | |
WO2012019430A8 (zh) | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 | |
WO2012019427A8 (zh) | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 | |
WO2009156462A3 (en) | Organic compounds | |
MX358679B (es) | Derivado de anillo de heteroarilo de seis miembros de pirrol, método de preparación del mismo y usos médicos del mismo. | |
WO2012065019A3 (en) | Combination comprising pyridopyrimidinone inhibitors of pi3k alpha | |
WO2007149907A3 (en) | Pyrazoloquinazolinones as parp inhibitors | |
CA2873723A1 (en) | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase | |
WO2014045162A8 (en) | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS | |
WO2010128050A3 (en) | Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2011143772A9 (en) | Inhibitors of hiv replication | |
WO2009013545A3 (en) | Chemical compounds | |
WO2011132051A3 (en) | Tricycle compounds as phosphodiesterase-10 inhibitors | |
WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
WO2011141488A3 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
WO2014036502A3 (en) | Tetracycline compounds | |
WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
WO2012118308A3 (ko) | 피라졸 유도체를 포함하는 심혈관 질환 예방 및 치료용 조성물. | |
WO2012140596A8 (en) | Glycoside derivatives and uses thereof | |
WO2009094457A3 (en) | Substituted benzhydrylethers | |
WO2011088160A3 (en) | Novel cyp17 inhibitors | |
WO2014062838A3 (en) | Pkm2 modulators and methods for their use | |
WO2010121675A3 (en) | Thiazolyl-benzimidazoles | |
WO2011123524A3 (en) | Macrolide inhibitors of mtor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180004612.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11815989 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11815989 Country of ref document: EP Kind code of ref document: A1 |